Lombard Odier Asset Management (USA)’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
EC
ACH
BG
Lombard Odier Asset Management (USA)'s TNDM Position: Q4 2023 in Review
Lombard Odier Asset Management (USA) sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 8,225 shares — an estimated $171K sold.
Lombard Odier Asset Management (USA) first reported a position in TNDM in Q3 2023 and held it in 1 quarter. The position peaked at $171K in Q3 2023. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.
- Lombard Odier Asset Management (USA) reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
- Lombard Odier Asset Management (USA) sold 8,225 Tandem Diabetes Care shares in Q4 2023, an estimated $171K.
- Lombard Odier Asset Management (USA) first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 1 quarter.
- Lombard Odier Asset Management (USA)'s Tandem Diabetes Care position peaked at $171K in Q3 2023.
- 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.
Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2023, filed 14 Feb 2024.